PBM Transparency Is Now a CFO Question
The U.S. Department of Labor opened 2026 with a clear signal: pharmacy benefit manager compensation is no longer something employers can leave in a black box. The proposed rule would require PBM service providers to give detailed fee and compensation disclosures to fiduciaries of employer-sponsored self-insured health plans. It would also give plan fiduciaries audit rights over those disclosures.
M3 Insurance, a Midwest benefits firm, framed the same market shift for employers by pointing to the DOL proposal and the broader 2026 federal PBM reforms. The market message is simple: PBM transparency is moving from a talking point to a governance issue.
That matters because pharmacy is not a side bill anymore. For many employers, it is one of the fastest-moving parts of the health plan. Specialty drugs, rebates, spread pricing, formulary decisions, and manufacturer payments can all affect the real cost of the plan. The employer may see a clean renewal sheet, but the money underneath it can move in several directions.
Why This Matters To Self-Funding
A fully insured employer can still care about PBM reform, but a self-funded employer owns the claim cost. That changes the question. The issue is not only whether the PBM contract is legal. The issue is whether the business can understand who gets paid, how they get paid, and whether that arrangement is reasonable for the plan.
That is a CEO and CFO issue. If the company pays the claims, the company should not accept mystery pricing as a normal part of the deal. A self-funded plan without PBM visibility is like a P&L with a major cost center labeled "trust us."
ERISA already expects plan fiduciaries to act with care. The new PBM disclosure push makes the standard more practical. It says, in plain English, that employers need enough information to judge the arrangement. If the information is missing, that is not just annoying. It is a decision problem.
The Business Review
Before renewal, leadership should ask for the PBM economics in writing. Not a sales summary. Not a promise that the arrangement is competitive. A written explanation that a business owner can read and a CFO can test.
Start with the money flow:
- What does the plan pay for each drug category?
- What does the pharmacy receive?
- What rebates, fees, credits, or manufacturer payments are expected?
- Who keeps those dollars?
- Can the employer audit the answer?
Those questions do not accuse anyone of wrongdoing. They create a clean business file. That file matters when the renewal is high, when an employee needs an expensive medication, or when leadership asks why the plan did not perform as expected.
What Superior Insurance Advisors Looks For
At Superior Insurance Advisors, the PBM conversation belongs inside the larger health plan review. Paul H. Flowers Jr. does not treat pharmacy as a separate maze that only specialists can understand. The point is to translate the structure into decisions a business leader can make.
The practical review is straightforward. Compare the PBM contract, claims data, rebate handling, formulary incentives, stop-loss treatment, and renewal assumptions. Then ask whether the plan design rewards lower net cost or just shifts cost to another column.
Paul.Health exists for this kind of plain-English review. The goal is not to turn every CEO into a pharmacy expert. The goal is to help leadership ask better questions before the company signs another year of costs it cannot explain.
The Decision File
Here is the simple checklist I would want in the file before renewal:
- A copy of the PBM agreement or pharmacy section of the plan arrangement.
- A summary of direct and indirect PBM compensation.
- Rebate pass-through terms, including timing and exclusions.
- Spread pricing, claw-back, and price protection language.
- Formulary decision rules and conflict-of-interest disclosures.
- Audit rights and the person responsible for using them.
- A one-page pharmacy performance summary leadership can understand.
If the answer to those items is "we do not know," that is the decision. The company is not ready to renew with confidence.
The Question To Ask Now
Before the next renewal, ask this: if our PBM had to show every dollar of compensation and every major incentive in a board meeting, would we be comfortable with the arrangement?
If not, do not wait for the rule to force the conversation. Start the review now. The employers that move early will have more leverage, cleaner files, and fewer surprises when pharmacy costs show up in the renewal.
Sources reviewed: U.S. Department of Labor PBM fee disclosure fact sheet and M3 Insurance PBM reform summary.